Human Longevity's Oncology Division

Human Longevity's Oncology Division

Human Longevity's Oncology Division

Acquired by
NeoGenomics
1
13 Jan 2020
$37,000,000
$37,000,000
Xconomy

NeoGenomics Nabs Human Longevity’s Oncology Division for $37M